Form D · Biotechnology
BennuBio, Inc.
Albuquerque, NM · CIK 0001751568
Offering snapshot reported Mar 23, 2022 · SEC filing
- Reported sold
- $1.32M Offering amount: $2M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 2, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 23, 2022 | Initial | $1,324,723 | No comparison | 13 | SEC filing |
| Mar 26, 2020 | Initial | $5,000,000 | No comparison | 5 | SEC filing |
| Aug 31, 2018 | Initial | $500,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-438474
Source: Form D, filed Mar 23, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Blivin | Director |
| Sally Corning | Director |
| R. Terry Dunlay | Director |
| James Freyer | Executive |
| Steven Graves | Director, Executive |
| Xin Huang | Director |
| Stephen Mc Kernan | Executive |
| Waneta Tuttle | Director |
| Travis Woods | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6610 Gulton Ct Ne
Albuquerque, NM, 87109
Albuquerque, NM, 87109